Targeting the epigenetic landscape of ECFCs: a new opportunity to enhance vascular repair.

Authors

Yaqiong Liu, Caomhán John Lyons, Christine Ayu Lagonda, Yingquan Luo, Lin Cheng, Zhenfei Fang

Published in

Angiogenesis. Volume 29. Issue 4. Oct 25, 2026. Epub Oct 25, 2026.

Abstract

Endothelial colony-forming cells (ECFCs) are endothelial progenitor cells characterized by robust proliferative and vasculogenic capacities, making them promising candidates for therapeutic tissue revascularization. However, the clinical application of ECFCs is hindered by their functional impairment under pathological conditions, such as diabetes and cardiovascular disease. Accumulating evidence indicates that aberrant epigenetic modifications, including DNA methylation, histone modifications, and non-coding RNA-mediated regulation, have been implicated in disease-associated ECFC dysfunction. In this review, we summarize current insights into the epigenetic regulation of ECFCs in pathological contexts, discuss epigenetic intervention strategies aimed at restoring ECFC function, and further highlight the therapeutic potential of ECFC-derived extracellular vesicles (EVs) as carriers of epigenetic cargo that promotes vascular repair. Collectively, a deeper understanding of the epigenetic landscape of ECFCs and ECFC-derived EVs may facilitate the development of novel therapeutic approaches for vascular regeneration and accelerate the clinical translation of ECFC- and EV-based therapies.

PMID:
42927513
Bibliographic data and abstract were imported from PubMed on 26 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.